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Abstract
Dengue viruses circulate in both human and sylvatic cycles. Although dengue viruses (DENV) infecting humans can cause
major epidemics and severe disease, relatively little is known about the epidemiology and etiology of sylvatic dengue
viruses. A 20-year-old male developed dengue hemorrhagic fever (DHF) with thrombocytopenia (12,000/ul) and a raised
hematocrit (29.5% above baseline) in January 2008 in Malaysia. Dengue virus serotype 2 was isolated from his blood on day
4 of fever. A phylogenetic analysis of the complete genome sequence revealed that this virus was a member of a sylvatic
lineage of DENV-2 and most closely related to a virus isolated from a sentinel monkey in Malaysia in 1970. This is the first
identification of a sylvatic DENV circulating in Asia since 1975.
Citation: Cardosa J, Ooi MH, Tio PH, Perera D, Holmes EC, et al. (2009) Dengue Virus Serotype 2 from a Sylvatic Lineage Isolated from a Patient with Dengue
Hemorrhagic Fever. PLoS Negl Trop Dis 3(4): e423. doi:10.1371/journal.pntd.0000423
Editor: Eva Harris, University of California Berkeley, United States of America
Received December 22, 2008; Accepted March 27, 2009; Published April 28, 2009
Copyright:  2009 Cardosa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was performed during the course of routine fever surveillance and was funded through the operational budget of the Institute of Health and
Community Medicine, Universiti Malaysia Sarawak. The authors had no grant funding nor sponsors for the work described here.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jane.cardosa@gmail.com
Introduction
Dengue viruses cause dengue fever (DF) and dengue hemor-
rhagic fever (DHF) in the tropics from Southeast and Southern
Asia, the Caribbean, and many countries in South and Central
America, and outbreaks are reported with increasing frequency
globally. The four distinct dengue virus serotypes (DENV-1 to
DENV-4) belong to the family Flaviviridae and are among the most
important vector-borne pathogens of humans, causing up to 100
million cases annually.
Dengue viruses are mosquito-transmitted and circulate in both
a sylvatic (enzootic) cycle involving non-human primates and
various species of Aedes mosquito (such as Ae. furcifer, Ae.
luteocephalus and Ae. taylori), and in a human (endemic) cycle
principally vectored by Aedes aegypti [1,2,3]. The only sylvatic
DENV serotype that has been isolated in Africa is DENV-2. In
contrast, sylvatic DENV-1, DENV-2 and DENV-4 have been
isolated in Asia [2], although the last isolation of a sylvatic virus
(of DENV-4) occurred in 1975, and the ‘sylvatic’ isolate of
DENV-1 is not phylogenetically distinct from human lineages so
that its origin is uncertain. Phylogenetic data suggests that
sylvatic DENV are the ancestors of those viruses that now
circulate endemically in human populations [2]. Importantly,
sylvatic dengue viruses have never been associated with major
epidemics in humans [4]. Here we report a case of dengue
hemorrhagic fever from whom we isolated a DENV-2 which was
determined by phylogenetic analysis to be a sylvatic strain most
closely related to a virus isolated by Rudnick from a sentinel
monkey in peninsular Malaysia in 1970 [5].
Materials and Methods
The context
Our laboratory provides virology support in the state of
Sarawak, Malaysia, part of which involves the isolation of virus
from the blood of patients suspected of having DF or DHF. This is
conducted as part of routine investigations for fever, which
includes ruling out both dengue and malaria. Two primary care
clinics and the university health centre act as sentinel clinics for
public health surveillance to detect dengue in the community.
During this routine surveillance program we isolated a sylvatic
virus from a dengue febrile patient.
Ethics statement
Further investigation of the virus isolated was performed after
consultation with the patient and he has provided written consent
to allow publication of his case.
Virus isolation
Serum from the blood drawn at presentation was inoculated
into C6/36 mosquito cells. When a cytopathic effect characteristic
of DENV was noted, the culture was harvested and RNA
extracted using the High Pure Nucleic Acid Extraction kit (Roche
Diagnostics, Indianapolis, IN) and RT PCR performed to amplify
a part of the NS5 gene using primers mFU1 and CFD2 as
described by Chien and coworkers [6]. The amplicon was purified,
sequenced and submitted to a BLAST search that returned a
match to DENV-2. We then amplified the E/NS1 junction using
primers AS2622DEN2 and S11871DEN2 [7] and used the
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isolate, then designated DKD811.
The complete genome of isolate DKD811 was sequenced using
overlapping degenerate primer sets spanning the whole genome
that were designed using the Primaclade software [8] available at
http://dousta.umsl.edu/cgi-bin/primaclade.cgi. A consensus se-
quence based on alignments of the complete genome sequences of
DENV-2 sylvatic strains obtained from GenBank was used as the
template for primer design. The PCR cycling conditions for all the
overlapping primer sets included an initial denaturation step at
95uC for 5 minutes followed by 35 cycles of 95uC for 30 seconds,
55uC for 30 seconds and 72uC for 1 minute. A final extension at
72uC for 5 minutes was performed after the last cycle. The
genome ends were sequenced using protocols for the Rapid
Amplification of cDNA Ends (RACE) from Invitrogen (CA, USA).
All amplified products were gel purified using the GENECLEAN
III kit (BIO101, CA, USA) and were sequenced in both directions
using the respective primers used to generate the PCR product.
Sequencing was done using BigDye v3.1 (Applied Biosystems, CA,
USA) and run on the 3130 Genetic Analyzer (Applied Biosystems,
CA, USA).
IgM capture ELISA (MAC ELISA)
The presence of dengue specific IgM was determined using a
routine MAC ELISA described previously [9] for both dengue and
Japanese encephalitis virus (JEV) run in parallel in order to
discriminate DENV and JEV responses. Two sets of antigens were
used: a mosquito cell derived cocktail of DENV-1, DENV-2,
DENV-3 and DENV-4, and JEV separately. Specific responses to
these antigens were determined using monoclonal antibodies to a
dengue group reactive epitope and to JEV.
Plaque reduction neutralization test (PRNT50)
The PRNT50 test was performed essentially as originally
described by deMadrid and Porterfield [10] using PS Clone D cells
and a semi solid carboxymethylcellulose overlay. Four fold serial
dilutions of heat inactivated acute and convalescent sera from the
patient taken 4 weeks apart, were incubated for 1 hour at 37uCi n
duplicate in 24 well plates. The cell suspension was then added
and allowed to adhere at 37uC for 2 hours before addition of
overlay. The plates were incubated for 5 days before the
monolayer was stained and plaques counted.
Phylogenetic analysis
To determine the evolutionary history of DKD811 we
performed a phylogenetic analysis on 58 complete coding
sequences of DENV-2 (total alignment length of 10,173 nt).
Specifically, we inferred a Maximum Clade Credibility (MCC)
tree using the Bayesian Markov Chain Monte Carlo (MCMC)
method available in the BEAST package [11], thereby
incorporating information on virus sampling time. This analysis
utilized a strict molecular clock and a GTR+C model of
nucleotide substitution for each codon position, although very
similar results (with no major differences in topology or
coalescent times) were obtained under a relaxed (uncorrelated
lognormal) molecular clock and different substitution models
(results available from the authors on request). As demographic
history is a nuisance parameter in our study, we utilized the
Bayesian skyline model as a coalescent prior. All chains were run
for a sufficient length to ensure convergence with 10% removed
as burn-in. This analysis also allowed us to estimate coalescent
(divergence) times for each node on the DENV-2 phylogeny.
The degree of uncertainty in each parameter estimate is
provided by the 95% highest posterior density (HPD) values,
while posterior probability values provide an assessment of the
degree of support for each node on the tree.
Results/Discussion
The case
A 20-year old previously healthy male university student was
admitted into a hospital in Sarawak (a Malaysian state on the
island of Borneo) on January 3
rd 2008 for suspected dengue
infection. He had returned to the university campus only two days
before his hospital admission, having spent 4 weeks of end-of-
semester vacation in peninsular Malaysia.
A day before his return to Sarawak, he fell ill with high fever
and chills. He sought medical attention at the university health
centre on day 4 of illness when his fever persisted with further signs
and symptoms of increased fatigue, anorexia, recurrent vomiting
and bouts of diarrhea. There was no history of cough, coryza, sore
throat, conjunctivitis, skin rash, headache, arthralgia, myalgia,
retro-orbital pain, bone pain, bleeding tendencies or abdominal
pain. On examination, he looked lethargic, was febrile (37.5uC)
and mildly dehydrated. No skin rashes or petechia were noted.
The tourniquet test was negative. The other systemic examina-
tions, including lung and abdomen, were unremarkable, and he
was provided with symptomatic treatment. His blood investigation
showed the following: hemoglobin 16.4 g/dL, hemotocrit 47.5%,
white cell count 3200/uL (neutrophils 69.3%, lymphocytes 22.9%)
and platelet count 81000/uL (Table 1).
On the following day, he was admitted into hospital after his
platelet count (performed at the university health centre) dropped
further to 35000/uL. Examination at hospital admission revealed
that he had facial flush and was dehydrated. His body temperature
was 39.6uC, blood pressure was 112/72 mmHg and pulse rate was
81/min. Apart from mild hepatomegaly, the other systemic
examinations, including cardiovascular and lung, revealed no
abnormality. He was treated with intravenous fluid for rehydra-
tion. The results of laboratory investigations performed on
admission and during his hospitalization are shown in Table 1.
His fever resolved rapidly within 12 hours after hospital admission.
Apart from having pruritic skin petechiae on his legs, there was no
other spontaneous bleeding, overt clinical signs of plasma leakage
such as pleural effusion, ascites or circulatory disturbance during
the first 48 hours after defervescence. A blood investigation on day
16 of illness showed a platelet count of 527,000/uL and a
Author Summary
Dengue viruses are mosquito-borne RNA viruses that
cause a spectrum of illness from mild disease to life-
threatening dengue hemorrhagic fever (DHF). Dengue
viruses exist in two separate cycles in nature, circulating in
either non-human primates or humans. The viruses that
are endemic in humans today most likely evolved from
non-human primate dengue viruses a few hundred years
ago and have since established themselves as four distinct
serotypes in human populations, causing periodic epi-
demics and severe disease. During the course of routine
surveillance for dengue transmission in Malaysia during
2008, a sylvatic dengue virus type 2 was isolated from a
young human male with DHF. The complete genome
sequence of the virus was determined and found to be
closely related to that isolated from a monkey in a similar
region of Malaysia in 1970. This is the first sylvatic dengue
virus isolated in Asia for more than 30 years.
Sylvatic Dengue from a DHF Case
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patient’s hematocrit had risen by 29.5% above his baseline. These
clinical features are consistent with DHF grade II [12].
IgM to DENV was absent in the first serum specimen but IgM
seroconversion was demonstrated to DENV in the convalescent
serum specimen taken a month after the first, confirming the
diagnosis of DENV infection. DENV specific IgG was positive in
the acute serum specimen and the convalescent specimen showed
a high level of broadly reactive IgG to the flaviviruses DENV and
JEV, suggesting a secondary immune response to DENV. Plaque
reduction neutralization tests (PRNT50) with acute and convales-
cent sera against the patient’s own DENV-2 isolate showed a
seroconversion from ,1:10 to 1:2560, confirming that this patient
had an established DENV-2 infection.
Evolutionary history of DKD811
Our complete genome phylogenetic analysis clearly revealed
that isolate DKD811 fell within the sylvatic lineage of DENV-2
and was most closely related to isolate P8-1407 sampled in
Malaysia in 1970 (Figure 1). This phylogenetic history was
supported by high posterior probability values (1.0). In addition,
our molecular clock analysis suggested that these two Malaysian
sylvatic viruses last shared a common ancestor approximately 63
years ago (95% HPD of 58–68 years), so that DENV-2 is likely to
have been circulating in non-human primates in Malaysia for at
least this time. Finally, this analysis suggested that the sylvatic and
human lineages of DENV-2 last shared a common ancestor 368
years ago (95% HPD of 336–399 years, which is similar to
previous estimates [13].
Table 1. Laboratory investigations by day of illness.
Day of Illness
Day 4 Day 5
a Day 6 Day 7 Day 8 Day 9
b Day 16 Day 37
Temperature 37.5 39.6 37 37 36.5 - - -
Hemoglobin (g/dL) 16.4 16.4 15.8 14.9 14.1 13.3 13.0 -
Total white cells (per uL) 3200 2600 4900 5300 4000 4400 5200 -
Platelets (per uL) 81000 32000 15000 12000 21000 53000 527000 -
Hematocrit (%) 47.5 50.9 48.3 44.3 43.7 40.1 39.3 -
Hemoconcentration (%) 20.9
c 29.5
c 22.9
c 12.7 11.2 2.0 - -
Lymphocytes (%) 22.9 - - - - - 42.9 -
Neutrophils (%) 69.3 - - - - - 48.8 -
Prothrombin (sec) - 13.6 - - - - - -
Partial Thromboplastin Time (sec) - 61.6 - - - - - -
Sodium (mmol/L) - 128 126 - - - - -
Total Bilirubin (umol/L) - 16 - - - - - -
AST
d (U/L) - 405 - - - - - -
ALT
e (U/L) - 194 - - - - - -
Total protein (g/L) - 83 - - - - - -
Albumin (g/L) - 46 - - - - - -
Alkaline Phosphotase (U/L) - 62 - - - - - -
Virus isolation DENV2 - - - - - - -
MAC ELISA
Adj ODf DENV 0.202 - - - - - - 0.818
Adj OD JEV 0.079 0.183
DENV cut off OD 0.380 0.380
JEV cut off OD 0.280 0.280
GAC ELISA
g
Adj OD DENV 0.564 - - - - - - 1.140
Adj OD JEV 0.389 1.140
DENV cut off OD 0.400 0.400
JEV cut off OD 0.315 0.315
aDay of admission.
bDay of discharge.
c.20% hemoconcentration.
dAspartate aminotransferase (AST).
eAlanine aminotransferase (ALT).
fAdjusted optical density (Adj OD).
gIgG-capture ELISA (GAC ELISA).
doi:10.1371/journal.pntd.0000423.t001
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Through a fever surveillance programme, we identified a
patient with DHF grade II who had been infected with a sylvatic
strain of DENV-2. This case is significant for several reasons. In
particular, this is the first recorded isolation of a sylvatic DENV
virus in Asia since 1975 and sylvatic isolates in general are
characterized by their rarity. Given that DKD811 is most closely
related to another Malaysia sylvatic virus (P8-1407) that was
isolated in 1970, we surmise that DENV-2 was resident in non-
human primates in this geographical location for the interim 38
years but without detection. Notably, our molecular clock analyses
suggest that DENV-2 may been in Malaysian monkeys for at least
60 years.
It is also noteworthy that this sylvatic isolate of DENV-2 was
associated with severe disease. Specifically, the virus was isolated
from a single patient with DHF who had been on vacation in an
area of the country where large numbers of dengue cases have
been reported. Further, the sentinel monkey study site of Rudnick
and colleagues was located in the same general area along the
southern slopes of the Main Range in peninsula Malaysia, where
the patient spent the 4 weeks prior to onset of illness. Although we
were unable to ascertain if the sylvatic DENV-2 we isolated was
circulating widely in the area our patient visited, the potential for a
re-introduction of ancestral DENV2- into the human population
should be evaluated [1].
This is the first report of a sylvatic dengue virus causing DHF,
providing a unique opportunity to investigate whether this strain can
cause DHF in non-human primates either as a primary or secondary
infection. Non-human primates have been utilized to study some
aspects of dengue infection, but in general the read-outs have been
the level of viremia as well as other non-specific indicators of the
establishment of an infection, together with the production of
neutralizing antibodies [14–16]. In addition, the infecting viruses
have not been of sylvatic origin. The identification of this sylvatic
strain provides hope of being able to induce features of DHF such as
thrombocytopenia, vascular leakage and hemoconcentration.
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